Navigation Links
Sigma-Aldrich (Nasdaq: SIAL) Announces Executive Management Changes: Retirement of David Julien and Promotion of Joseph Porwoll
Date:5/14/2010

ST. LOUIS, May 14 /PRNewswire-FirstCall/ -- Sigma-Aldrich announces the retirement of David Julien, President – Global Supply Chain effective on June 30, 2010.  Mr. Julien took on his current role in January 2009.  He served as President of the Research Specialties unit of the Company from July 2005 to January 2009 and before that in a number of senior roles including that of President of the Research Biotech unit of the Company.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20050215/CGSIGMAALLOGO)

The Company is pleased to announce that Joseph Porwoll has been promoted to Vice President, Global Supply Chain and will take over the responsibilities held by Mr. Julien.  Mr. Porwoll holds a PhD in chemistry from the University of Minnesota and has been with the Company for 26 years in roles of increasing responsibility, most recently as Vice President of the Company's Wisconsin-based operations.

President and CEO Jai Nagarkatti commented, "We thank Dave Julien for his tremendous leadership and contributions over the years.  He played an integral role in making our Company a global player in the life sciences industry.  While we are sad to see Dave leave us and wish him well in his retirement, we are pleased to add Joe Porwoll to our executive team.  Joe is a strong manager with substantial experience and skill in manufacturing, distribution, procurement and planning functions.  This internal promotion is indicative of the commitment we have to developing talent at Sigma-Aldrich.  Joe is expected to build upon Dave's work in streamlining our global supply chain creating a competitive advantage by enhancing service and thereby enabling our customers' success."

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. We have customers in life science companies, university and government institutions, hospitals and in industry. Over one million scientists and technologists use our products. Sigma-Aldrich operates in 38 countries and has 7,600 employees providing excellent service worldwide. We are committed to Accelerating our Customers' Success through Innovation and Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit our award winning web site at http://www.sigma-aldrich.com


'/>"/>
SOURCE Sigma-Aldrich
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
2. Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies
3. Sigma-Aldrich Expansion in Republic of China to Support SAFC Growth
4. Sigma-Aldrich and Ingenuity Systems Announce Partnership to Create E-Commerce Search Solution Based on Biological Knowledge
5. Sigma-Aldrich to Present at the UBS 2007 Global Life Sciences Conference on September 25, 2007
6. Sigma-Aldrich Names Patrick Sullivan New VP of Research and Development for Research Biotech
7. Sigma-Aldrich and the Universite de Montreal Establish Collaboration for RNA Interference Studies
8. Sigma-Aldrich Corporations 3rd Quarter 2007 Earnings Conference Call
9. Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types
10. Sigma-Aldrich (Nasdaq: SIAL) Q3 2007 Sales Increase 14.0%, Yielding Diluted EPS of $.54.
11. Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... 28, 2017  The National Pharmaceutical Council (NPC) today ... policy research organization as its newest member. David ... ( North America ), will serve as ... "We,re pleased to have Ipsen and Dr. Cox ... Leonard . "We welcome their insights in helping us ...
(Date:3/28/2017)... ... March 28, 2017 , ... Currently symptomatic therapies for Parkinson’s ... study published in STEM CELLS suggests that human neural stem cell (hNSC) transplantation ... produce more neural cells. , Strategies involving transplantation of these cells into ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... as Chief Executive Officer with Avomeen Analytical Services. Harvill is a distinguished life ... operations. , Avomeen is a leader in a wide range of services ...
(Date:3/27/2017)... Infectex Ltd., a Russian portfolio company of Maxwell Biotech Venture Fund (MBVF), today ... standard drug therapy regimen in patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). SQ109 is a ... ) and the US National Institutes of Health. Continue ... ... ...
Breaking Biology Technology:
(Date:3/23/2017)... , Mar. 23, 2017 Research and Markets ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 8.8% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
(Date:3/20/2017)... PMD Healthcare announces the release of its ... System (WMS), a remote, real-time lung health monitoring and ... is a Medical Device, Digital Health, and Chronic Care ... innovative solutions that empower people to improve their healthcare ... developed the first ever personal spirometer, Spiro PD, which ...
(Date:3/7/2017)... 7, 2017 Brandwatch , the leading social intelligence ... Prince,s Trust to uncover insights to support its reporting, help ... The UK,s leading youth charity will be using Brandwatch Analytics ... get a better understanding of the topics and issues that are ... ...
Breaking Biology News(10 mins):